Financial Synergies Wealth Advisors, Inc. Eagle Pharmaceuticals, Inc. Transaction History
Financial Synergies Wealth Advisors, Inc.
- $822 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
9Shares Held
453KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY353KShares$694,9410.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$111,1820.92% of portfolio
-
Barclays PLC London, X014.2KShares$28,0390.0% of portfolio
-
Stanley Laman Group, Ltd. Berwyn, PA12KShares$23,6400.0% of portfolio
-
Hightower 6 M Holding, LLC8.86KShares$17,4580.02% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $25.6M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...